Feeds
11084 items (11084 unread) in 74 feeds
Acinar Cell Carcinoma
(102 unread)
Acinic Cell Carcinoma
(77 unread)
Adenoid Cystic Carcinoma
(186 unread)
Adrenal Gland Cancer
(861 unread)
Ampulla Of Vater
(120 unread)
Anal Cancer
(958 unread)
Angiosarcoma
(192 unread)
Appendix Cancer
(270 unread)
Bile Duct Cancer
(1493 unread)
Brain and CNS
(1338 unread)
Carcinoid
(392 unread)
Endocrine/Neuroendocrine
(1243 unread)
Gall Bladder Cancer
(631 unread)
Hemangioendothelioma
(281 unread)
Hepatoblastoma
(216 unread)
Pancreas
(249 unread)
Phyllodes
(121 unread)
PMP and Mucinous Tumors
(138 unread)
Rhabdomyosarcoma
(378 unread)
Sarcoma
(1838 unread)
Google - Angiosarcoma (100 unread)
1
2
-
![Permalink for '[Full text] CT and MRI findings of head and neck Masson's tumor | RMI - Dove Medical Press'](/themes/orange-slice/web/media/pl.gif)
[Full text] CT and MRI findings of head and neck Masson's tumor | RMI - Dove Medical Press
Posted: April 14th, 2021, 8:09pm GMT
[Full text] CT and MRI findings of head and neck Masson's tumor | RMI Dove Medical Press -
Soft Tissue Sarcomas Treatment Market Poised for Growth | Key Players – Sanofi, Cardinal Health, Merck KGaA. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: April 14th, 2021, 9:47am GMT
-
Who Is Natalie Viscuso? Meet Henry Cavill's New Girlfriend - ELLE Australia
Posted: April 12th, 2021, 9:15pm GMT
Who Is Natalie Viscuso? Meet Henry Cavill's New Girlfriend ELLE Australia -
Angiosarcomas Treatment Market Size Will Escalate Rapidly in the Near Future - The Courier
Posted: April 12th, 2021, 8:28am GMT
-
5 things to know about Henry Cavill's new girlfriend Natalie Viscuso - 9TheFIX
Posted: April 12th, 2021, 10:50pm GMT
-
Dr. Wagner on the Rationale for Immunotherapy in Angiosarcoma - OncLive
Posted: April 5th, 2021, 6:23pm GMT
-
A Pilot Study of Lenvatinib and Pembrolizumab Immunotherapy in People with Advanced Soft Tissue Sarcoma - On Cancer - Memorial Sloan Kettering
Posted: April 5th, 2021, 3:38pm GMT
A Pilot Study of Lenvatinib and Pembrolizumab Immunotherapy in People with Advanced Soft Tissue Sarcoma On Cancer - Memorial Sloan Kettering -
Michael Greenwood Obituary (2021) - Phoenix, AZ - The Arizona Republic - Legacy.com
Posted: April 1st, 2021, 5:00am GMT
-
A Phase II Study Assessing the Addition of Nivolumab to Chemotherapy to Treat Angiosarcoma - On Cancer - Memorial Sloan Kettering
Posted: March 23rd, 2021, 2:10pm GMT
A Phase II Study Assessing the Addition of Nivolumab to Chemotherapy to Treat Angiosarcoma On Cancer - Memorial Sloan Kettering -
Angiosarcomas Treatment Market 2020 – Precise Outlook, Status & Forecast Till 2027 – Jumbo News - Jumbo News
Posted: March 22nd, 2021, 9:49am GMT
-
Heart Tumor Market to Hit CAGR of +7% 2028 | Tomtec Imaging Systems GmBh, Koninklijke Philips N.V., Siemens Healthineers, Circle Cardiovascular Imaging Inc., Toshiba Corporation, Shimadzu Corporation, CardioComm Solutions Inc., Integer Holdings Corporati
Posted: March 22nd, 2021, 8:10am GMT
-
[Full text] Tyrosine Kinase Inhibitors in Soft Tissue Sarcoma | CMAR - Dove Medical Press
Posted: March 17th, 2021, 6:48pm GMT
[Full text] Tyrosine Kinase Inhibitors in Soft Tissue Sarcoma | CMAR Dove Medical Press -
Verna Boyd Obituary (2021) - Hanover, VA - Richmond Times-Dispatch - Legacy.com
Posted: March 15th, 2021, 5:00am GMT
-
Hepatic vascular malignancies in children are associated with increased rates of surgical resection and improved overall survival compared with adults - MD Linx
Posted: March 10th, 2021, 7:20pm GMT
-
Angiosarcomas Treatment Market SWOT Analysis, Segmentation, Applications & Emerging Audience Till 2027 – Breakout Live - Breakout Live
Posted: March 9th, 2021, 11:48am GMT
-
'Unintended consequences': The rubber industry's toxic legacy in Akron – Center for Public Integrity - Center for Public Integrity
Posted: March 5th, 2021, 3:37pm GMT
'Unintended consequences': The rubber industry's toxic legacy in Akron – Center for Public Integrity Center for Public Integrity -
Stage 4 Liver Cancer: Overview and More - Verywell Health
Posted: March 5th, 2021, 6:00am GMT
Stage 4 Liver Cancer: Overview and More Verywell Health -
Sarcoma Drugs Market Present Scenario, Key Vendors, Industry Share, and Growth Forecast up to 2027 - The Courier
Posted: March 4th, 2021, 5:56pm GMT
-
Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers - GenomeWeb
Posted: March 3rd, 2021, 6:00pm GMT
-
Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers - Precision Oncology News
Posted: March 3rd, 2021, 6:00pm GMT
Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers Precision Oncology News -
Dr. Wagner on the Safety Profile of Nivolumab/Ipilimumab in Angiosarcoma - OncLive
Posted: March 2nd, 2021, 8:41pm GMT
-
Angiosarcomas Treatment Market 2019 Trends, Size Analysis, Share, Leading Companies, Future Insight - PharmiWeb.com
Posted: March 2nd, 2021, 8:10am GMT
-
Global Soft Tissue Sarcomas Treatment Market Is Growing With A CAGR Of 6.49% 2021-2028 | Sanofi, Car - PharmiWeb.com
Posted: March 2nd, 2021, 6:29am GMT
-
Athenex, Inc. (ATNX) Q4 2020 Earnings Call Transcript - Motley Fool
Posted: March 1st, 2021, 9:30pm GMT
-
Phio, AgonOx Collaborate To Develop T Cell-based Cancer Immunotherapies - Quick Facts - Nasdaq
Posted: March 1st, 2021, 11:11am GMT
-
Edited Transcript of ATNX.OQ earnings conference call or presentation 1-Mar-21 1:00pm GMT - Yahoo Finance
Posted: March 1st, 2021, 11:00am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - StreetInsider.com
Posted: March 1st, 2021, 10:08am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - StreetInsider.com
Posted: March 1st, 2021, 10:05am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - GlobeNewswire
Posted: March 1st, 2021, 6:00am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - GlobeNewswire
Posted: March 1st, 2021, 6:00am GMT
-
Taking A Gander At Tracon Pharmaceuticals - Seeking Alpha
Posted: February 28th, 2021, 4:58am GMT
Taking A Gander At Tracon Pharmaceuticals Seeking Alpha -
Taking A Gander At Tracon Pharmaceuticals - Seeking Alpha
Posted: February 28th, 2021, 4:58am GMT
Taking A Gander At Tracon Pharmaceuticals Seeking Alpha -
TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
Posted: February 27th, 2021, 8:36pm GMT
-
Healthcare Industry: Global Soft Tissue Sarcomas Treatment Market s growing with a CAGR of 6.49% 2021-2028 – The Bisouv Network - The Bisouv Network
Posted: February 25th, 2021, 8:45am GMT
-
Impact of Covid-19 on Global Soft Tissue Sarcomas Treatment Market s growing with a CAGR of 6.49% 2021-2028 – The Courier - The Courier
Posted: February 25th, 2021, 8:31am GMT
-
Global Soft Tissue Sarcomas Treatment Market is growing with a CAGR of 6.49% 2021-2028 | Sanofi, Cardinal Health, Merck KGaA, Pfizer, Bristol-Myers Squibb Company, Johnson & Johnson Services – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: February 25th, 2021, 8:18am GMT
-
Former patient drives cancer community - Sandton Chronicle
Posted: February 25th, 2021, 6:44am GMT
Former patient drives cancer community Sandton Chronicle -
Randy Rosen Rink officially named after hockey coach with terminal cancer - FortSaskOnline.com
Posted: February 21st, 2021, 3:12pm GMT
Randy Rosen Rink officially named after hockey coach with terminal cancer FortSaskOnline.com -
Next-Generation Sequencing Unearths Actionable Mutations in Sarcoma - www.oncnursingnews.com/
Posted: February 21st, 2021, 3:06pm GMT
Next-Generation Sequencing Unearths Actionable Mutations in Sarcoma www.oncnursingnews.com/ -
Canine Hemangiosarcoma – Cancer in Dogs - The Bark
Posted: February 19th, 2021, 6:54am GMT
-
Right atrial cardiac angiosarcoma treated with concurrent proton beam therapy and paclitaxel: A novel approach to a rare disease - DocWire News
Posted: February 19th, 2021, 4:00am GMT
-
Next-Generation Sequencing Reveals Potentially Actionable Mutations in Sarcoma - OncLive
Posted: February 18th, 2021, 2:02pm GMT
-
[Full text] Clinical Characteristics and Prognostic Factors in Pediatric Vascular | PHMT - Dove Medical Press
Posted: February 15th, 2021, 7:01pm GMT
-
Ken Pribil Jr. Foundation Supports Angiosarcoma Research at Memorial Sloan Kettering Cancer Center for a Third Year - WFMZ Allentown
Posted: February 15th, 2021, 12:00pm GMT
-
Ken Pribil Jr. Foundation Supports Angiosarcoma Research at Memorial Sloan Kettering Cancer Center for a Third Year - PR Web
Posted: February 15th, 2021, 6:00am GMT
-
First Patient-Led Cancer Registry Launched With Support From Altron Karabina - Africa.com
Posted: February 10th, 2021, 5:23am GMT
-
Global SAR Market Research Report 2025 – NeighborWebSJ - NeighborWebSJ
Posted: February 10th, 2021, 11:15pm GMT
Global SAR Market Research Report 2025 – NeighborWebSJ NeighborWebSJ -
Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic - BioSpace
Posted: February 8th, 2021, 6:00am GMT
-
Study Finds Niraparib Plus Temozolomide or Irinotecan Tolerable in Pretreated Ewing Sarcoma - Cancer Network
Posted: February 6th, 2021, 6:00am GMT
-
First patient-led cancer registry launches with support from Altron Karabina on World Cancer Day - ITWeb
Posted: February 5th, 2021, 6:00am GMT
-
[Full text] Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin F | CMAR - Dove Medical Press
Posted: February 4th, 2021, 6:00am GMT
-
Loving father from Lowestoft diagnosed with rare cancer - Lowestoft Journal
Posted: February 2nd, 2021, 6:00am GMT
Loving father from Lowestoft diagnosed with rare cancer Lowestoft Journal -
Neoadjuvant Systemic Therapy Induces Fair Response Rate for High-Risk Retroperitoneal Sarcoma - Cancer Network
Posted: January 23rd, 2021, 6:00am GMT
-
CES 2021: Medical technologies you need to know | Page 8 of 10 - Medical Design & Outsourcing
Posted: January 8th, 2021, 6:00am GMT
CES 2021: Medical technologies you need to know | Page 8 of 10 Medical Design & Outsourcing -
Study identifies distinct sub-types of aggressive tumours to allow for targeted treatment - Medical Xpress
Posted: December 28th, 2020, 6:00am GMT
-
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS) - Yahoo Finance
Posted: November 17th, 2020, 6:00am GMT
-
Dual Checkpoint Blockade Active in Rare Tumors - MedPage Today
Posted: November 15th, 2020, 6:00am GMT
Dual Checkpoint Blockade Active in Rare Tumors MedPage Today -
Rare angiosarcoma tumors respond well to immunotherapy combination - Medical Xpress
Posted: November 13th, 2020, 6:00am GMT
-
Legacy of West Ham fan David Chapman lives on with memorial football kit - Eastern Daily Press
Posted: November 4th, 2020, 6:00am GMT
Legacy of West Ham fan David Chapman lives on with memorial football kit Eastern Daily Press -
Mitchell, Betty “Marie” Dotson - The Chattanoogan
Posted: October 27th, 2020, 5:00am GMT
Mitchell, Betty “Marie” Dotson The Chattanoogan -
Lehho Rebassoo Obituary - (2020) - Peekskill, NY - Albany Times Union - Legacy.com
Posted: October 25th, 2020, 5:00am GMT
-
Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewswire
Posted: October 14th, 2020, 5:00am GMT
-
FDA Grants Priority Review to Oral Paclitaxel, Encequidar Combo for Metastatic Breast Cancer - Cancer Network
Posted: September 1st, 2020, 5:00am GMT
-
Bradford mother donates stem cells to help save daughter's life - BarrieToday
Posted: August 14th, 2020, 5:00am GMT
-
Athenex, Inc. Reports Second Quarter Ended June 30, 2020 Financial Results and Provides Corporate Update - GlobeNewswire
Posted: August 6th, 2020, 5:00am GMT
-
Vail Valley Charitable Fund: This isn't my first rodeo - Vail Daily News
Posted: August 6th, 2020, 5:00am GMT
Vail Valley Charitable Fund: This isn't my first rodeo Vail Daily News -
NCI Trials for August 2020 - The Cancer Letter
Posted: August 6th, 2020, 5:00am GMT
NCI Trials for August 2020 The Cancer Letter -
Agenus Provides R&D Update & Second Quarter Financial Report - BioSpace
Posted: August 6th, 2020, 5:00am GMT
-
Global Liver Cancer Therapeutics Market, By Cancer Type, By Therapy, By Equipment, By Age, By Factors, By Route of Administration, By Distribution channel, By Region, Competition, Forecast & Opportunities, 2025 - GlobeNewswire
Posted: August 4th, 2020, 5:00am GMT
-
Daredevil Mansfield woman in wing walk fundraiser for John Eastwood Hospice - Mansfield and Ashfield Chad
Posted: July 26th, 2020, 5:00am GMT
Daredevil Mansfield woman in wing walk fundraiser for John Eastwood Hospice Mansfield and Ashfield Chad -
A 61-year-old woman with chronic leg lymphedema managed with complete decongestive therapy - CMAJ
Posted: June 29th, 2020, 5:00am GMT
-
XAF1 as a modifier of p53 function and cancer susceptibility - Science Advances
Posted: June 24th, 2020, 5:00am GMT
XAF1 as a modifier of p53 function and cancer susceptibility Science Advances -
XAF1 as a modifier of p53 function and cancer susceptibility - Science Advances
Posted: June 24th, 2020, 5:00am GMT
XAF1 as a modifier of p53 function and cancer susceptibility Science Advances -
Owens & Minor announces $50m offering - Mass Device
Posted: May 22nd, 2020, 5:00am GMT
Owens & Minor announces $50m offering Mass Device -
FDA Approves Pomalidomide for Patients with AIDS-Related Kaposi Sarcoma - Cancer Network
Posted: May 15th, 2020, 5:00am GMT
-
Caris Life Sciences to Present Data Spotlighting Clinical Impact of Precision Medicine in ASCO20 Virtual Scientific Program - BioSpace
Posted: May 11th, 2020, 5:00am GMT
-
Runners find solace, purpose in virtual races - Tampa Bay Times
Posted: May 5th, 2020, 5:00am GMT
Runners find solace, purpose in virtual races Tampa Bay Times -
Immunotherapy Combination Induces Promising ORR in Patients With Advanced Sarcoma - Targeted Oncology
Posted: February 4th, 2020, 6:00am GMT
-
Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook - BioSpace
Posted: January 29th, 2020, 6:00am GMT
-
On the Double: Immunotherapy Combinations in Liver Cancer - Curetoday.com
Posted: September 24th, 2019, 5:00am GMT
-
Dr. D'Angelo on Bempegaldesleukin/Nivolumab Combo in Sarcomas - OncLive
Posted: September 3rd, 2019, 5:00am GMT
-
Cutaneous angiosarcoma rates increasing in those older than 70 years - Healio
Posted: July 18th, 2019, 5:00am GMT
-
VEGFR Targeted Therapies and Combinations Emerge for the Treatment of Sarcomas - Targeted Oncology
Posted: July 1st, 2019, 5:00am GMT
-
Ewing, Pediatric, Kaposi & Soft Tissue Sarcoma Resource & Info Center - Cancer Therapy Advisor
Posted: February 27th, 2019, 1:09pm GMT
Ewing, Pediatric, Kaposi & Soft Tissue Sarcoma Resource & Info Center Cancer Therapy Advisor -
Rockville Centre's Ken Pribil Jr. Foundation donates $15K for cancer research - liherald.com
Posted: January 23rd, 2019, 6:00am GMT
-
Texas Tech medical research helps fight cancer - El Paso Times
Posted: March 10th, 2018, 9:20am GMT
Texas Tech medical research helps fight cancer El Paso Times -
Immunotherapy Offers New Strategy for Treating Sarcoma - Memorial Sloan Kettering Cancer Center
Posted: January 22nd, 2018, 6:00am GMT
Immunotherapy Offers New Strategy for Treating Sarcoma Memorial Sloan Kettering Cancer Center -
Princeton student Jacob Kaplan, computer science major, dies Read more - Princeton University
Posted: December 27th, 2017, 6:00am GMT
Princeton student Jacob Kaplan, computer science major, dies Read more Princeton University -
Combined Immunotherapy Shows Promise in Certain Sarcoma Subtypes - Cancer Network
Posted: November 9th, 2017, 6:00am GMT
-
A Breast Cancer-Related Rash? - Leigh Valley Magazine
Posted: October 25th, 2017, 5:00am GMT
A Breast Cancer-Related Rash? Leigh Valley Magazine -
Former Celtic Justin Reed passes away from cancer at age 35 - ProBasketballTalk
Posted: October 20th, 2017, 5:00am GMT
Former Celtic Justin Reed passes away from cancer at age 35 ProBasketballTalk -
Sarcoma: Symptoms, types, treatments, and causes - Medical News Today
Posted: September 19th, 2017, 8:54pm GMT
Sarcoma: Symptoms, types, treatments, and causes Medical News Today -
TRACON Pharmaceuticals Announces First Patient Dosed In Phase 3 TAPPAS Trial Of TRC105 In AngioSarcoma - Clinical Leader
Posted: February 16th, 2017, 6:00am GMT
-
University of Minnesota develops cancer drug that helps dogs with hemangiosarcoma - VetPracticeNews.com
Posted: February 14th, 2017, 6:00am GMT
-
TRACON Pharmaceuticals Receives Special Protocol Assessment (SPA) Agreement From FDA For Phase 3 Clinical Trial Of TRC105 In Angiosarcoma - Clinical Leader
Posted: January 3rd, 2017, 6:00am GMT
-
Epidemiology and Outcomes of Angiosarcoma - MedicalResearch.com
Posted: December 27th, 2016, 6:00am GMT
Epidemiology and Outcomes of Angiosarcoma MedicalResearch.com -
Researchers say it's time to consider propranolol as an anti-cancer drug - Science Daily
Posted: October 13th, 2016, 5:00am GMT
-
TRACON Pharmaceuticals Announces Successful Meetings With FDA And EMA For TRC105 (carotuximab) In Angiosarcoma - Clinical Leader
Posted: October 3rd, 2016, 5:00am GMT
-
Detection of Intrathoracic Bleeding by 99mTc-Labeled Red Blood Cell SPECT/CT After Wedge Biopsy of Pulmonary Angiosarcoma - Journal of Nuclear Medicine Technology
Posted: September 1st, 2016, 5:00am GMT
Detection of Intrathoracic Bleeding by 99mTc-Labeled Red Blood Cell SPECT/CT After Wedge Biopsy of Pulmonary Angiosarcoma Journal of Nuclear Medicine Technology -
Novel Drug Combination Shows Activity in Angiosarcoma - Cancer Network
Posted: June 7th, 2016, 5:00am GMT
Novel Drug Combination Shows Activity in Angiosarcoma Cancer Network
1
2